{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:28:35Z","timestamp":1773883715167,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["118566"],"award-info":[{"award-number":["118566"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cytogfr.2025.12.002","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:14:31Z","timestamp":1764782071000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Post COVID-19 pandemic Inflammatory Insights into Cancer: Consequences for immunotherapy"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2052-3330","authenticated-orcid":false,"given":"Carla","family":"Eksteen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9-chandr\u00e9","family":"Asja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atarah","family":"Rass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Riedemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Mart","family":"Engelbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2025.12.002_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cytogfr.2021.10.005","article-title":"Cancer and Covid-19: Collectively catastrophic","volume":"63","author":"du Plessis","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.002_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med"},{"key":"10.1016\/j.cytogfr.2025.12.002_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.annepidem.2025.02.004","article-title":"Higher prevalence of long COVID observed in cancer survivors: Insights from a US nationwide survey","volume":"103","author":"Wang","year":"2025","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.cytogfr.2025.12.002_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/2021.06.25.449905","article-title":"Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection","volume":"12","author":"Patterson","year":"2021","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.002_bib5","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae","volume":"76","author":"Swank","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.002_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/cid\/ciab465","article-title":"Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients","volume":"74","author":"Ogata","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"23","key":"10.1016\/j.cytogfr.2025.12.002_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024202118","article-title":"The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-\u0399","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.002_bib8","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cbin.11517","article-title":"Dysregulation of the immune response in coronavirus disease 2019","volume":"45","author":"Mohamed Khosroshahi","year":"2021","journal-title":"Cell Biol. Int"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.002_bib9","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Clin. Rheuma"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.002_bib10","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: Current State of the Science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.002_bib11","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: Neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.cytogfr.2025.12.002_bib12","doi-asserted-by":"crossref","first-page":"1260776","DOI":"10.3389\/fmolb.2023.1260776","article-title":"SARS-CoV-2 infection as a potential risk factor for the development of cancer","volume":"10","author":"Ogarek","year":"2023","journal-title":"Front Mol. Biosci."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.002_bib13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.cytogfr.2025.12.002_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153918","article-title":"The Role of Chronic Inflammation in the Development of Breast Cancer","volume":"13","author":"Danforth","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6382","key":"10.1016\/j.cytogfr.2025.12.002_bib15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2025.12.002_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.866014","article-title":"IL-6\/JAK\/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment","volume":"12","author":"Manore","year":"2022","journal-title":"Front Oncol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.002_bib17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and Significance of the Pre-metastatic Niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13058-020-01360-0","article-title":"COVID-19: a potential driver of immune-mediated breast cancer recurrence?","volume":"22","author":"Francescangeli","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.002_bib19","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13058-020-01293-8","article-title":"COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area","volume":"22","author":"Vuagnat","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"10223","key":"10.1016\/j.cytogfr.2025.12.002_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.002_bib22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"10234","key":"10.1016\/j.cytogfr.2025.12.002_bib23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cytogfr.2025.12.002_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark. Res"},{"issue":"11","key":"10.1016\/j.cytogfr.2025.12.002_bib26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cytogfr.2025.12.002_bib27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway","volume":"10","author":"Khan","year":"2021","journal-title":"Elife"},{"issue":"27","key":"10.1016\/j.cytogfr.2025.12.002_bib28","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/onc.2013.302","article-title":"The Yin and Yang of Toll-like receptors in cancer","volume":"33","author":"Pradere","year":"2014","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.12.002_bib29","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nat. Med"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.12.002_bib30","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/nm1325","article-title":"Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity","volume":"11","author":"Kortylewski","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167563","article-title":"Linking COVID-19 and cancer: Underlying mechanism","volume":"1871","author":"Tyagi","year":"2025","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"issue":"7985","key":"10.1016\/j.cytogfr.2025.12.002_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2025.12.002_bib33","doi-asserted-by":"crossref","first-page":"1502937","DOI":"10.3389\/fimmu.2024.1502937","article-title":"Identification of an immunological signature of long COVID syndrome","volume":"15","author":"Guerrera","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.002_bib34","article-title":"Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis","volume":"11","author":"Shen","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.cytogfr.2025.12.002_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biochi.2020.11.010","article-title":"The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response","volume":"180","author":"Icard","year":"2021","journal-title":"Biochimie"},{"issue":"22","key":"10.1016\/j.cytogfr.2025.12.002_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212223","article-title":"Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment","volume":"25","author":"Wang","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.cytogfr.2025.12.002_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: an awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.12.002_bib39","article-title":"Hypoxia-Inducible Factor 1-Alpha (HIF-1\u03b1) and Cancer: Mechanisms of Tumor Hypoxia and Therapeutic Targeting","volume":"16","author":"Basheeruddin","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40249-023-01086-z","article-title":"Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis","volume":"12","author":"Yin","year":"2023","journal-title":"Infect. Dis. Poverty"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.002_bib41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.12.002_bib42","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3389\/fimmu.2018.02039","article-title":"Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses","author":"Grandi","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2025.12.002_bib43","doi-asserted-by":"crossref","first-page":"1597370","DOI":"10.3389\/fimmu.2025.1597370","article-title":"Mitochondrial metabolic rescue in post-COVID-19 syndrome: MR spectroscopy insights and precision nutritional therapeutics","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib44","doi-asserted-by":"crossref","first-page":"14086","DOI":"10.1038\/s41598-023-41115-3","article-title":"SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication","volume":"13","author":"Montezano","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.002_bib45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","article-title":"Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2","volume":"25","author":"Yin","year":"2024","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.002_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.002_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.70034","article-title":"Monitoring Macrophage Polarization in Infectious Disease, Lesson From SARS-CoV-2 Infection","volume":"35","author":"Mezouar","year":"2025","journal-title":"Rev. Med. Virol."},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.002_bib48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/oncolo\/oyab083","article-title":"Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer","volume":"27","author":"Tan","year":"2022","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.cytogfr.2025.12.002_bib49","article-title":"Impact of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review","volume":"16","author":"Bocquet-Gar\u00e7on","year":"2024","journal-title":"Cureus"},{"issue":"23","key":"10.1016\/j.cytogfr.2025.12.002_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235954","article-title":"Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy","volume":"14","author":"Hatic","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.cytogfr.2025.12.002_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17121948","article-title":"Periodic Boosters of COVID-19 Vaccines Do Not Affect the Safety and Efficacy of Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: A Longitudinal Analysis of the Vax-On-Third Study","volume":"17","author":"Fabbri","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"21","key":"10.1016\/j.cytogfr.2025.12.002_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216812","article-title":"Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19","volume":"12","author":"Sabbatino","year":"2023","journal-title":"J. Clin. Med"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib53","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1186\/s12885-025-14318-2","article-title":"Early mortality in patients with cancer and COVID-19 infection treated with immunotherapy","volume":"25","author":"Raphael","year":"2025","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.cytogfr.2025.12.002_bib54","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s43018-022-00398-7","article-title":"Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy","volume":"3","author":"Walle","year":"2022","journal-title":"Nat. Cancer"},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.002_bib55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-023-05922-w","article-title":"SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cytogfr.2025.12.002_bib56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2020.09.028","article-title":"A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19","volume":"141","author":"Yeked\u00fcz","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cytogfr.2025.12.002_bib57","doi-asserted-by":"crossref","first-page":"m2980","DOI":"10.1136\/bmj.m2980","article-title":"Drug treatments for covid-19: living systematic review and network meta-analysis","volume":"370","author":"Siemieniuk","year":"2020","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-020-01019-5","article-title":"Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients","volume":"13","author":"Chen","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.cytogfr.2025.12.002_bib59","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.annonc.2020.06.007","article-title":"COVID-19 in patients with lung cancer","volume":"31","author":"Luo","year":"2020","journal-title":"Ann. Oncol."},{"issue":"10241","key":"10.1016\/j.cytogfr.2025.12.002_bib60","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.002_bib61","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1470-2045(21)00155-8","article-title":"Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors","volume":"22","author":"Waissengrin","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cytogfr.2025.12.002_bib62","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fcvm.2022.997660","article-title":"Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment","volume":"9","author":"Ganesh","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2025.12.002_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102513","article-title":"Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis","volume":"16","author":"Ahmed","year":"2022","journal-title":"Diabetes Metab. Syndr."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.002_bib64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.002_bib65","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.12.002_bib67","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.002_bib68","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T Cell Dysfunction in Cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2025.12.002_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2025.12.002_bib70","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114150","article-title":"Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19","volume":"13","author":"Theobald","year":"2021","journal-title":"EMBO Mol. Med"},{"issue":"10","key":"10.1016\/j.cytogfr.2025.12.002_bib71","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cytogfr.2025.12.002_bib72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.smim.2018.09.003","article-title":"The integration of inflammaging in age-related diseases","volume":"40","author":"Fulop","year":"2018","journal-title":"Semin Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2025.12.002_bib73","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1148\/radiol.2021211746","article-title":"CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge","volume":"303","author":"Vijayakumar","year":"2022","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.cytogfr.2025.12.002_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084537","article-title":"NLRP3 Inflammasome in Acute and Chronic Liver Diseases","volume":"25","author":"Sayaf","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.cytogfr.2025.12.002_bib75","doi-asserted-by":"crossref","first-page":"e1130","DOI":"10.1093\/cid\/ciaa1759","article-title":"Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions","volume":"72","author":"Meyerowitz","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2025.12.002_bib76","doi-asserted-by":"crossref","first-page":"1185716","DOI":"10.3389\/fimmu.2023.1185716","article-title":"Tocilizumab versus anakinra in COVID-19: results from propensity score matching","volume":"14","author":"Arcani","year":"2023","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2025.12.002_bib77","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41375-020-0891-0","article-title":"The Janus kinase 1\/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation","volume":"34","author":"La Ros\u00e9e","year":"2020","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.cytogfr.2025.12.002_bib78","doi-asserted-by":"crossref","first-page":"C554","DOI":"10.1152\/ajpcell.00323.2020","article-title":"Overlapping and distinct biological effects of IL-6 classic and trans-signaling in vascular endothelial cells","volume":"320","author":"Montgomery","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2025.12.002_bib79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.stem.2020.01.017","article-title":"C\/EBP\u03b2-Dependent Epigenetic Memory Induces Trained Immunity in Hematopoietic Stem Cells","volume":"26","author":"de Laval","year":"2020","journal-title":"Cell Stem Cell"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610125001583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:43:48Z","timestamp":1773863028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610125001583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":79,"alternative-id":["S1359610125001583"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.12.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post COVID-19 pandemic Inflammatory Insights into Cancer: Consequences for immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2025.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}